South Dakota § 34-20B-12 Specific substances included in Schedule I.

South Dakota Statutes

§ 34-20B-12 — Specific substances included in Schedule I.

South Dakota § 34-20B-12

Title 34PUBLIC HEALTH AND SAFETY

Ch. 34-20DRUGS AND SUBSTANCES CONTROL

This text of South Dakota § 34-20B-12 (Specific substances included in Schedule I.) is published on Counsel Stack Legal Research, covering South Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

S.D. Codified Laws § 34-20B-12 (2026).

Text

Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule I, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

(1)Acetylmethadol;

(2)Allylprodine;

(3)Alphacetylmethadol, except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate or LAAM;

(4)Alphameprodine;

(5)Alphamethadol;

(6)Benzethidine;

(7)Betacetylmethadol;

(8)Betameprodine;

(9)Betamethadol;

(10)Betaprodine;

(11)Clonitazene;

(12)Dextromoramide;

(13)Diampromide;

(14)Diethyliambutene;

(15)Dimenoxadol;

(16)Dimepheptanol;

(17)Dimethyliambutene;

(18)

Free access — add to your briefcase to read the full text and ask questions with AI

Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule I, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Acetylmethadol; (2) Allylprodine; (3) Alphacetylmethadol, except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate or LAAM; (4) Alphameprodine; (5) Alphamethadol; (6) Benzethidine; (7) Betacetylmethadol; (8) Betameprodine; (9) Betamethadol; (10) Betaprodine; (11) Clonitazene; (12) Dextromoramide; (13) Diampromide; (14) Diethyliambutene; (15) Dimenoxadol; (16) Dimepheptanol; (17) Dimethyliambutene; (18) Dioxaphetyl butyrate; (19) Dipipanone; (20) Ethylmethylthiambutene; (21) Etonitazene; (22) Etoxeridine; (23) Fenethylline; (24) Furethidine; (25) Hydroxypethidine; (26) Ketobemidone; (27) Levomoramide; (28) Levophenacylmorphan; (29) Mecloqualone; (30) Morpheridine; (31) Noracymethadol; (32) Norlevorphanol; (33) Normethadone; (34) Norpipanone; (35) Phenadoxone; (36) Phenampromide; (37) Phenomorphan; (38) Phenoperidine; (39) Piritramide; (40) Proheptazine; (41) Properidine; (42) Racemoramide; (43) Trimeperidine; (44) Methaqualone; (45) N-benzylpiperazine; (46) 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide, W-18; (47) N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine, also known as isotonitazene; (48) 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (butonitazene); (49) 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (etodesnitazene, etazene); (50) N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (flunitazene); (51) N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (metodesnitazene); (52) N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (metonitazene); (53) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (N-pyrrolidino etonitazene, etonitazepyne); (54) N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene); (55) 7-[(10,11-dihydro-5 H -dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) (amineptine); (56) N -phenyl- N′ -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) (mesocarb); and (57) N -methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine).

Legislative History

SL 1970, ch 229, § 8 (a) (1); SDCL Supp, § 39-17-55; SL 1977, ch 315, § 1; SL 1985, ch 278, § 50; SL 1994, ch 278, § 1; SL 2003, ch 183, § 1; SL 2018, ch 203, § 1, eff. Feb. 8, 2018; SL 2021, ch 144, § 1, eff. Feb. 17, 2021; SL 2022, ch 109, § 1, eff. Feb. 9, 2022; SL 2024, ch 130, § 1, eff. Feb. 14, 2024.